Related Experiment Video
Updated: Jan 8, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Bisphenol P induces ovarian dysfunction by directly targeting PTGS2 and disrupting steroid hormone synthesis
Dingmei Qin1, Zijian Ma1, Zhipeng Lin1
1Anhui Province Key Laboratory of Embryo Development and Reproductive Regulation, Anhui Province Key Laboratory of Pollution Damage and Biological Control for Huaihe River Basin, Fuyang Normal University, Fuyang, Anhui 236037, China.
Abstract:
Emerging evidence suggests structural analogues of bisphenol A (BPA), including the increasingly used substitute bisphenol P (BPP), pose substantial reproductive risks. However, BPP's ovarian toxicity remains uncharacterized. This study used an integrated approach combining in vivo models, network toxicology, transcriptomics, molecular docking, and biophysical techniques to elucidate the mechanisms of BPP-induced ovarian injury in peripubertal female mice. Eight-week BPP exposure caused significant ovarian injury, including follicular atresia, disorganized granulosa cells, elevated DNA damage, and apoptosis. While the ovarian index was unchanged, serum hormone trends indicated decreased estradiol (E2) and increased luteinizing hormone (LH). An integrated network toxicology and transcriptomics approach identified prostaglandin-endoperoxide synthase 2 (PTGS2) as a pivotal target. The direct interaction between BPP and PTGS2 was confirmed by molecular docking and quantitatively validated using microscale thermophoresis (MST, Kd = 61.2 ± 29.9 μM) and surface plasmon resonance (SPR, Kd = 2.6 ± 0.6 μM). Mechanistically, BPP triggered a multi-level suppression of the steroidogenic pathway, significantly downregulating genes encoding gonadotropin receptors (Lhcgr, Fshr), key transcription factors (Nr5a1, Foxl2), and rate-limiting enzymes (Star, Cyp11a1, Hsd3b, Cyp19a1). Our findings demonstrate that BPP acts as a potent ovarian toxicant by directly targeting PTGS2 and instigating a comprehensive transcriptional blockade of steroid hormone synthesis, revealing a novel mechanistic pathway for this emerging environmental contaminant. Collectively, this work elucidates a novel mechanism of BPP-induced ovarian toxicity and establishes an integrated assessment framework that paves the way for evaluating the reproductive health risks of emerging environmental contaminants.
Insights
Bisphenol P (BPP) causes ovarian toxicity by targeting PTGS2 and disrupting steroid hormone synthesis. This study reveals a novel mechanism for BPP
Area of Science:
- Environmental Toxicology
- Reproductive Toxicology
- Molecular Toxicology
Background:
- Structural analogues of Bisphenol A (BPA), like Bisphenol P (BPP), are suspected reproductive toxicants.
- The specific ovarian toxicity of BPP remains largely uncharacterized.
- Understanding BPP's impact is crucial due to its increasing use as a BPA substitute.
Purpose of the Study:
- To elucidate the mechanisms underlying BPP-induced ovarian injury in peripubertal female mice.
- To investigate BPP's effects on ovarian structure, function, and molecular pathways.
- To identify key molecular targets and pathways affected by BPP exposure.
Main Methods:
- In vivo mouse models (peripubertal females) with 8-week BPP exposure.
- Integrated network toxicology and transcriptomics analysis.
- Molecular docking, microscale thermophoresis (MST), and surface plasmon resonance (SPR) for interaction validation.
- Analysis of ovarian morphology, DNA damage, apoptosis, and serum hormone levels (estradiol, LH).
Main Results:
- BPP exposure induced significant ovarian injury, including follicular atresia, granulosa cell disorganization, DNA damage, and apoptosis.
- Serum hormone analysis showed decreased estradiol and increased luteinizing hormone.
- Prostaglandin-endoperoxide synthase 2 (PTGS2) was identified as a direct BPP target, with confirmed binding via molecular docking and biophysical methods (MST, SPR).
- BPP suppressed the steroidogenic pathway by downregulating key genes (Lhcgr, Fshr, Nr5a1, Foxl2, Star, Cyp11a1, Hsd3b, Cyp19a1).
Conclusions:
- Bisphenol P (BPP) is a potent ovarian toxicant.
- BPP directly targets PTGS2, leading to a comprehensive transcriptional blockade of steroid hormone synthesis.
- This study establishes a novel mechanism for BPP-induced ovarian toxicity and an assessment framework for emerging environmental contaminants.
More Related Videos
04:49Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
Published on: July 5, 2024
08:28Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays
Published on: April 26, 2018
Related Concept Videos
Oogenesis
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Ovarian Cycle
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Teratogenicity
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...